Additionally, administrated Ro 61-6048, a KMO inhibitor, alleviated dystonia in an animal model [111,112], and reduced the levodopa-induced dyskinesia in PD animal model [113,114]. This evidence concerns the gene KMO and drug-induced dyskinesia.